Issued Patents 2002
Showing 1–11 of 11 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 6475783 | Isolated nucleic acid molecule coding for tumor rejection antigen precursors MAGE-C1 and MAGE-C2 and uses thereof | Sophie Lucas, Charles De Smet | 2002-11-05 |
| 6465184 | Isolated nucleic acid molecule encoding peptides which form complexes with MHC molecules HLA-Cw*1601 and uses thereof | Pascale Bo{haeck over (e)}l, Claude Wildmann, Pierre van der Bruggen, Pierre Coulie, Jean-Christophe Renauld | 2002-10-15 |
| 6429287 | Isolated molecules which complex with HLA-Cw*16 molecules, and uses thereof | Pierre van der Bruggen, Etienne DePlaen | 2002-08-06 |
| 6426217 | MAGE-3 peptides presented by HLA class II molecules | Pascal Chaux, Vincent Stroobant, Pierre van der Bruggen, Kris Thielemans, Jurgen Kurthals | 2002-07-30 |
| 6407063 | Tumor antigens and CTL clones isolated by a novel procedure | Rosalie Luiten, Marie-Therese Duffour, Nathalie Demotte, Pierre van der Bruggan, Guy Cornelius +2 more | 2002-06-18 |
| 6392016 | Isolated protein molecules which are members of the MAGE-B family | Christophe Lurquin, Francis Brasseur | 2002-05-21 |
| 6387630 | Methods for diagnosing multiple myeloma by determining rejection antigen precursors | Nicolas Van Baren, Francis Brasseur | 2002-05-14 |
| 6379901 | Method for screening for cancer using binders for MAGE related peptides and complexes of the peptide and HLA molecules | Pierre van der Bruggen, Etienne De Plaen, Christophe Lurguin, Catia Traversari, Beatrice Gaugler +1 more | 2002-04-30 |
| 6369211 | MAGE-3 peptides presented by HLA class II molecules | Pascal Chaux, Vincent Stroobant, Pierre van der Bruggen | 2002-04-09 |
| 6353089 | Method for stimulating CTLs with peptides | Pierre van der Bruggen, Catia Traversari, Katharina Fleischauer | 2002-03-05 |
| 6339149 | Isolated nucleic acid molecules which encode tumor rejection antigens found in dage | Pierre Coulie, Hideyuki Ikeda | 2002-01-15 |